Position in NVS
as of Mar 31, 2026
· filed Apr 13, 2026
Position Value
$281,976
+$27,468 QoQ
Shares Held
1,846
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital Advantage, Inc. holds $3,879,621 across 4 Drug Manufacturers - General names.
All Filings in NVS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $281,976 | 1,846 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $254,508 | 1,846 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $225,317 | 1,757 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $212,614 | 1,757 | Shares | Sole | 2025-07-11 | |
| No filing history on record for this holder in this stock. | ||||||